These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21062979)

  • 1. Induction of human epithelial stem/progenitor expansion by FOXM1.
    Gemenetzidis E; Elena-Costea D; Parkinson EK; Waseem A; Wan H; Teh MT
    Cancer Res; 2010 Nov; 70(22):9515-26. PubMed ID: 21062979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two mechanisms regulate keratin K15 expression in keratinocytes: role of PKC/AP-1 and FOXM1 mediated signalling.
    Bose A; Teh MT; Hutchison IL; Wan H; Leigh IM; Waseem A
    PLoS One; 2012; 7(6):e38599. PubMed ID: 22761689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells.
    Lok GT; Chan DW; Liu VW; Hui WW; Leung TH; Yao KM; Ngan HY
    PLoS One; 2011; 6(8):e23790. PubMed ID: 21858223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.
    Teh MT; Gemenetzidis E; Patel D; Tariq R; Nadir A; Bahta AW; Waseem A; Hutchison IL
    PLoS One; 2012; 7(3):e34329. PubMed ID: 22461910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes.
    Teh MT; Gemenetzidis E; Chaplin T; Young BD; Philpott MP
    Mol Cancer; 2010 Feb; 9():45. PubMed ID: 20187950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foxm1 expression in prostate epithelial cells is essential for prostate carcinogenesis.
    Cai Y; Balli D; Ustiyan V; Fulford L; Hiller A; Misetic V; Zhang Y; Paluch AM; Waltz SE; Kasper S; Kalin TV
    J Biol Chem; 2013 Aug; 288(31):22527-41. PubMed ID: 23775078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of Forkhead Box M1 transcription factor from respiratory epithelial cells inhibits pulmonary tumorigenesis.
    Wang IC; Meliton L; Ren X; Zhang Y; Balli D; Snyder J; Whitsett JA; Kalinichenko VV; Kalin TV
    PLoS One; 2009 Aug; 4(8):e6609. PubMed ID: 19672312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation.
    Gemenetzidis E; Bose A; Riaz AM; Chaplin T; Young BD; Ali M; Sugden D; Thurlow JK; Cheong SC; Teo SH; Wan H; Waseem A; Parkinson EK; Fortune F; Teh MT
    PLoS One; 2009; 4(3):e4849. PubMed ID: 19287496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic Kras(G12D.).
    Wang IC; Ustiyan V; Zhang Y; Cai Y; Kalin TV; Kalinichenko VV
    Oncogene; 2014 Nov; 33(46):5391-6. PubMed ID: 24213573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
    Wierstra I
    Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXM1 allows human keratinocytes to bypass the oncogene-induced differentiation checkpoint in response to gain of MYC or loss of p53.
    Molinuevo R; Freije A; de Pedro I; Stoll SW; Elder JT; Gandarillas A
    Oncogene; 2017 Feb; 36(7):956-965. PubMed ID: 27452522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foxm1 transcription factor is critical for proliferation and differentiation of Clara cells during development of conducting airways.
    Ustiyan V; Wert SE; Ikegami M; Wang IC; Kalin TV; Whitsett JA; Kalinichenko VV
    Dev Biol; 2012 Oct; 370(2):198-212. PubMed ID: 22885335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
    Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.
    Kong X; Li L; Li Z; Le X; Huang C; Jia Z; Cui J; Huang S; Wang L; Xie K
    Cancer Res; 2013 Jul; 73(13):3987-96. PubMed ID: 23598278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell line.
    Tüfekçi Ö; Yandım MK; Ören H; İrken G; Baran Y
    Leuk Res; 2015 Mar; 39(3):342-7. PubMed ID: 25557384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXM1 is a downstream target of Gli1 in basal cell carcinomas.
    Teh MT; Wong ST; Neill GW; Ghali LR; Philpott MP; Quinn AG
    Cancer Res; 2002 Aug; 62(16):4773-80. PubMed ID: 12183437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
    Fan Q; Cai Q; Xu Y
    Oncotarget; 2015 Sep; 6(29):27688-99. PubMed ID: 26299613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High FOXM1 expression was associated with bladder carcinogenesis.
    Liu D; Zhang Z; Kong CZ
    Tumour Biol; 2013 Apr; 34(2):1131-8. PubMed ID: 23325617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
    Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.
    Chiu WT; Huang YF; Tsai HY; Chen CC; Chang CH; Huang SC; Hsu KF; Chou CY
    Oncotarget; 2015 Feb; 6(4):2349-65. PubMed ID: 25537512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.